Spinal cord stimulation medication tapering study
Part of Pain clinical trials.
This study tests whether lowering pain medication can improve how well spinal cord stimulation works. It is for people who already take certain pain medicines and are scheduled to try a spinal cord stimulator.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to try a spinal cord stimulator (Evoke system).
- You have failed back surgery syndrome or failed neck surgery syndrome.
- You take at least one of these pain medicines at or above the listed daily dose: gabapentin 150 mg, pregabalin 75 mg, morphine 40 mg, hydromorphone 10 mg, oxycodone 20 mg, or fentanyl 25 mcg.
- You are at least 18 years old.
- You do not have an active psychiatric disorder, progressive neurological disease, bleeding problem, serious infection, or uncontrolled diabetes.
- You are not pregnant and have not had significant untreated addiction or substance abuse in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how changing your pain medications while using a spinal cord stimulator affects your nervous system. It may help people with chronic lower back pain find the best way to manage their pain and reduce reliance on strong drugs.
This trial tests how much of the pain relief from spinal cord stimulation is due to the placebo effect. It is for people with ongoing leg pain after back surgery who have already tried other treatments without success.
This trial tests a closed-loop spinal cord stimulator that adjusts stimulation based on nerve signals. It may help people with chronic pain who are already scheduled to try this type of device.
This trial tests a type of spinal cord stimulation (DTM SCS) for people with chronic leg or foot pain caused by nerve damage (PSPS-T2). It aims to see if this treatment can safely reduce pain and improve daily life.
This study compares two ways of delivering spinal cord stimulation to see which better reduces pain in people with persistent spinal pain syndrome type 2. You would be assigned to one of the stimulation “burst” patterns and followed for changes in your pain experience.
This trial tests whether stem cells injected near your spinal cord can improve pain relief from your existing spinal cord stimulator (BurstDR device). You're only eligible if your current stimulator is already helping with at least 50% pain reduction.
Hear when a new Failed Back Surgery Syndrome (FBSS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.